CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA

被引：0
|
作者：
Brouwer, W. P. [1 ]
Sonneveld, M. J. [1 ]
Xie, Q. [2 ]
Zhang, N. [3 ]
Zeuzem, S. [4 ]
Tabak, F. [5 ]
Zhang, Q. [6 ]
Simon, K. [7 ]
Akarca, U. S. [8 ]
Streinu-Cercel, A. [9 ]
Hansen, B. [1 ]
Janssen, H. L. [10 ]
机构：
[1] Erasmus MC, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Jiao Tong Univ, Ruijin Hosp, Gastroenterol & Hepatol, Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Zhong Shan Hosp, Gastroenterol & Hepatol, Shanghai 200433, Peoples R China
[4] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Gastroenterol & Hepatol, Frankfurt, Germany
[5] Cerrahpasa Med Fac, Gastroenterol & Hepatol, Istanbul, Turkey
[6] Fudan Univ, Shanghai Publ Hlth Ctr, Gastroenterol & Hepatol, Shanghai 200433, Peoples R China
[7] Wroclaw Med Univ, Gastroenterol & Hepatol, Wroclaw, Poland
[8] Ege Univ, Tip Fak, Gastroenterol & Hepatol, Bornova, Turkey
[9] Natl Inst Infect Dis, Gastroenterol & Hepatol, Bucharest, Romania
[10] Toronto Western & Gen Hosp, Univ Hlth Network, Ctr Liver Dis, Gastroenterol & Hepatol, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30873-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0669
引用
收藏
页码：S572 / S573
页数：2
相关论文
共 50 条
  • [1] Decline in Quantitative Serum HBsAg Level during Consolidation Therapy Following HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir
    Su, Wen-Pang
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    HEPATOLOGY, 2014, 60 : 1102A - 1103A
  • [2] A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB)
    Sheng, Jifang
    Bai, Xuefan
    Wu, Shuhuan
    Chen, Jianjie
    Sheng, Jifang
    Xie, Yao
    Chen, Chengwei
    Jiang, Michael
    Xie, Ding
    HEPATOLOGY, 2011, 54 : 1017A - 1017A
  • [3] Association between Genotype and the HBsAg Levels at HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir or Peginterferon Alfa-2a
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    HEPATOLOGY, 2014, 60 : 1121A - 1121A
  • [4] PEGINTERFERON IS SUPERIOR TO PROLONGED ENTECAVIR THERAPY FOR SEROLOGICAL RESPONSE IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Zoutendijk, Roeland
    Sonneveld, Milan J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2011, 54 : 1023A - 1023A
  • [5] ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Peng, C. -Y.
    Lai, H. -C.
    Su, W. -P.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S430 - S430
  • [6] Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels
    Shin, J. W.
    Jung, S. W.
    Park, B. R.
    Kim, C. J.
    Eum, J. B.
    Kim, B. G.
    Jeong, I. D.
    Bang, S. -J.
    Lee, S. -H.
    Kim, S. R.
    Park, N. H.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (10) : 724 - 731
  • [7] Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
    Gish, Robert G.
    Lok, Anna S.
    Chang, Ting-Tsung
    De Man, Robert A.
    Gadano, Adrian
    Sollano, Jose
    Han, Kwang-Hyub
    Chao, You-Chen
    Lee, Shou-Dong
    Harris, Melissa
    Yang, Joanna
    Colonno, Richard
    Brett-Smith, Helena
    GASTROENTEROLOGY, 2007, 133 (05) : 1437 - 1444
  • [8] ON-TREATMENT HBSAG LEVEL AND HBEAG INDEX CAN EARLY PREDICT HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B, HBEAG POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2A
    Phisalprapa, Pochamana
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Nimanong, Supot
    Prachayakul, Varayu
    Pausawasdi, Nonthalee
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 526A - 527A
  • [9] On-treatment HBsAg level and HBeAg index can early predict HBeAg seroconversion in chronic hepatitis B, HBeAg positive patients treated with peginterferon alpha-2a
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Nimanong, S.
    Pausawasdi, N.
    Prachayakul, V.
    Pongprasobchai, S.
    Udompanthurak, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    Tanwandee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A94 - A94
  • [10] Association of KIR Genotypes and Haplotypes in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir
    Zhuang, YunLong
    Li, XiXi
    Li, Xiaohua
    Xu, HuiCong
    Ye, Hui
    Sun, Di
    Liu, XiangZhong
    Ren, GuiJie
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (04) : 333 - 344
12345